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ABSTRACT
Background: Medicinal plants are the major sources of traditional 
treatment of disease and new drug discovery due to major side effects 
of synthetic drug. 
Objectives: The aim of study was to evaluate analgesic and antioxidant 
activities of petroleum ether and chloroform soluble fractions of whole 
plant extract of Acanthus ilicifoius. 
Materials and Methods: The plant extract, standard diclofenac, and 
distilled water as control was administered post orally in Swiss albino 
mice and observe the analgesic activity by acetic acid (0.6%) induced 
writhing method. The plant extract was also subjected to perform 
reducing power assay, DPPH free radical scavenging activity, and FRAP 
assay to evaluate antioxidant activity. 
Results: The pet ether, and chloroform soluble fraction of plant extract 
revealed significant analgesic activity on mice model. Notably, the pet 
ether and chloroform fraction showed (40.14 ± 2.32) % and (40.12 ± 
0.9) % analgesic inhibition, whereas standard diclofenac revealed 
(52.79 ± 2.62) % analgesic inhibition. In antioxidant activity assay, the 
plant extract showed mild to moderate antioxidant activities compare 
to standard ascorbic acid. 
Conclusion: From the results, it could be concluded that, the pet 
ether and chloroform fractions of whole plant extract of A. ilicifolius 
possesses potential analgesic and antioxidant properties.
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INTRODUCTION
The ancient people use medicinal plants in the treat-
ment of various diseases without proper therapeutic 
knowledge. But, now a days, many research is going 
on in the basis of natural medicinal plants to deter-
mine the pharmacological actions such as antioxi-
dant, antimicrobial, analgesic, antipyretic, sedative, 
antidepressant, anxiolytic, antipsychotic, anticancer, 
anti-diabetic and other different activities.1 Acanthus 
ilicifolius Linn. (Acanthaceae) is a perennial vascular 
plant, popularly recognized as “Holy leaved acan-
thus». Historically, the plant is employed in tradi-
tional systems of medicine, including traditional 
Indian medicine or ayurveda and in traditional 
Chinese medicine for the treatment of various 
ailments.2,3 The different parts of plant of A. ilicifolius 
such as fruits, leaves, bark, and roots are reported 
to possess various bioactive compounds such as 
triterpenoids, alkaloids, phenolic compounds, 
lignin, flavonoid, steroids, and terpenoids. Thus, 
the plant part or whole plants are reported to use in 
asthma, diabetes, hepatitis, inflammatory disease, 
and rheumatoid arthritis.2,4,5 Methanolic extract 
of leaves of A.   ilicifolius has been reported to exert 
hepatoprotective and tumor suppressive activities.6,7 
The plant parts have been used for the treatment of 
asthma, diabetes, dyspepsia, leprosy, hepatitis, paral-
ysis, rheumatoid arthritis and dieresis.4,8 Besides, 
the plant has been shown to possesses anti-inflam-
matory, antioxidant, antileishmanial, osteoblastic, 
hepatoprotective, anticancer, antiulcer and anti-
microbial activities.9 The plant is wealthy in bioac-
tive compounds and due to possess of biological 
activities the plant is frequently being investigated. 
According to Worlds Health Organization (WHO), 
more than 80% of world inhabitants depends on 
using plant for their medicine and mangroves have 
been widely used for that purpose.4 A. ilicifolius is a 
true mangrove species of plant and found in Asian 
tropics from India to Bangladesh, mangrove forest of 
Srilanka, Polynesia and northern Australia.10,11
Conventional non-steroidal anti-inflammatory 
drugs are common in the treatment of pain, bruise 
and inflammation. But, several adverse reactions 
are associated with these agents limiting the wide-
spread uses of the agents. Development of newer 
and safest anti-inflammatory compound possessing 
Department of Pharmacy, Faculty of Science, Noakhali Science and Technology University, Noakhali-3814, Bangladesh
*Correspondence to:  
Md. Hasanuzzaman, M.Pharm, PhD, 
Associate Professor, Department 
of Pharmacy, Faculty of Science, 
Noakhali Science and Technology 
University, Noakhali-3814, 
Bangladesh. 
hasanprdu@gmail.com
Cite This Article: Faysal, M.A.R., 
Barek, M.A., Sharmin Jahan,  
Shahid-Ud-Daula, A.F.M.,  
Basher, M.A., Hasanuzzaman, M.  
2020. Petroleum Ether and 
Chloroform Soluble Fractions of 
Whole Plant Extract of Acanthus 
ilicifolis Linn. Possesses Potential 
Analgesic and Antioxidant 
Activities. Discovery Phytomedicine 
7(1): 12-18. DOI:10.15562/
phytomedicine.2019.113
Volume No.: 7
Issue: 1
First page No.: 12
RH_Author: XXX
Doi: Discovery Phytomedicine.2020.113
Original Article
Petroleum Ether and Chloroform Soluble  
Fractions of Whole Plant Extract of Acanthus ilicifolis 
Linn. Possesses Potential Analgesic and Antioxidant 
Activities
Md. Abu Rayhan Faysal, Md. Abdul Barek, Sharmin Jahan, A. F. M. Shahid-Ud-Daula, 
Mohammad Anwarul Basher, Md. Hasanuzzaman*
www.phytomedicine.ejournals.ca Discovery Phytomedicine 2020; 7(1): 12-18. doi: 10.15562/phytomedicine.2020.113 13
Petroleum Ether and Chloroform ... Md. Hasanuzzaman, et al.
fewer side effects is a challenge to the scientific 
community. However, to search new anti-inflam-
matory components from medicinal plant is ongo-
ing and having a great interest of scientists.5
Free radical and reactive oxygen species are 
responsible for oxidative stress and different patho-
genesis such as inflammation, arthritis, diabetes, 
parkinson’s, alzheimer’s disease, as well as cancer 
and atherosclerosis. Those components are also 
responsible for human aging.12,13 The antioxidant 
molecules are defined as any substances that delays 
or inhibit oxidative damage to a target molecules.14 
They can trap free radical, peroxide, hydroperox-
ide or lipid peroxyl molecules to prevent oxidative 
damage of cells and protect from degenerative 
diseases.15 The use of synthetic antioxidant is an 
old practice, however several question may arise in 
consumer concerning safety issues. Thus, alterna-
tive or natural source of antioxidant from medici-
nal plants are attracting consumers.16
Despite its wide anecdotal uses, few pharmaco-
logical studies on whole plant have been performed. 
The aim of our research was therefore to examine 
the effect of petroleum ether (pet ether) and chlo-
roform soluble fractions of whole plant extract of 
A. ilicifolius on anti-oxidant and analgesic activity.
MATERIALS AND METHODS
Plant Materials and Extract Preparation
The whole plant of A. ilicifolius was collected from 
Sundarban, a mangrove forest situated in the south-
west coastal region of Bangladesh. The plant speci-
men was subjected to National Herbarium, Dhaka 
for identification. The experience taxonomist iden-
tified the plant sample and provided a identification 
number (accession number: Acc-46522). The plant 
was thoroughly washed, sun dried and powdered by 
rotary cutter mill. About 800 g of dried powder was 
taken in two clean, flat bottomed glass containers 
and soaked in 1500 ml of pet ether and 1500 ml of 
chloroform, respectively. The soaked plant extract 
was kept at room temperature for two weeks with 
occasional shaking and stirring. The whole mixture 
was filtered using filter cloth following a Whatman 
filter paper (Bibby RE200, Sterilin Ltd., UK). The 
filtrate was evaporated by using rotary evaporator 
(RE-EV311-V, LabTeck S.R.L, Italy) and then kept 
under ceiling fan for several days. It rendered a 
gummy concentrate of greenish black color. The 
gummy concentrate was designated as pet ether 
and chloroform soluble fraction and the extract was 
kept at 4 °C for further analysis.
Experimental Animals
The Swiss albino mice of both (male and female) 
sex weighing 20–30 g and aged 6–8 weeks were 
purchased from the animal house of the Department 
of Pharmacy, Jahangirnagar University, Dhaka-
Bangladesh. All of the animals were kept in plastic 
cages at room temperature and on a 12 h light-dark 
cycle. The animal had free access to standard pet 
diet (pellet food) and water ad libitum. The experi-
ment was done in the Physiology Laboratory of the 
Department of Pharmacy at Noakhali Science and 
Technology University. The mice were acclimatized 
to laboratory environment for 1 week prior to the 
experiment. Standard pet diet was withdrawn 18 h 
prior to the beginning of experiment. The care and 
handling was according to international guide-
lines for the use and maintenance of experimental 
animals.17
Analgesic Activity (Writhing Test)
The acetic acid induced writhing method is an 
analgesic behavioral observation assessment 
method that demonstrate a noxious stimulation in 
experimental animal.18 The experiment was done 
by following Nguemfo et  al. with little modifica-
tion.19 The mice were divided into 6 groups, each of 
containing six mice and denoted as control (distilled 
water), standard (diclofenac), pet ether 200, pet 
ether 400, chloroform 200, and chloroform 400. 
Mice were fasted for 18 hr prior to experiment and 
fed the treatment post orally. The dose of treatment 
were as like follows- DW 10 ml/kgbw, diclofenac 
100 mg/kgbw, pet ether extract 200 mg/kgbw, pet 
ether extract 400 mg/kgbw, chloroform extract 
200 mg/kgbw, and chloroform extract 400 mg/kgbw. 
After 1 hr of post oral treatment of control, stan-
dard, and plant extract, 0.6% of glacial acetic acid 
was introduced intraperitoneally. The writhing was 
observed for 15 minutes and the percentage of anal-
gesic activity was calculated as follows.19 
Antioxidant Activity
Reducing Power Assay
The reducing power assay is based on the principle 
of increase of absorbance of supplied sample pres-
ent in mixture. The higher the absorbance value 
indicates higher the reducing power.20 The experi-
ment was done by following published article with 
little modification.21,22 The 2.5 mL of 0.2 M phos-
phate buffer (pH 6.6) and 2.5 mL of K3Fe (CN)6 
(1% w/v) were added to various concentration 
(40-500 µl/mL) of plant extract dissolved in metha-
nol. The mixture was incubated at 50°C for 20 min, 
followed by addition of 2.5 mL of trichloroacetic 
acid (10% w/v). Then the mixture was centrifuged 
at 3000 rpm for 10 min to collect the supernatant 
(2.5 mL). The supernatant was mixed with distilled 
water (2.5 mL) and 0.5 mL of FeCl3 (0.1%, w/v). The 
absorbance was measured at 700 nm against blank 
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sample. Higher absorbance value indicates stronger 
reducing power. The antioxidant activity of plant 
extract was expressed as half maximal concentra-
tion of effective concentration (EC50) and the EC50 
value was calculated by equation (Y = mX + C; 
When Y = 0.5, X = EC50) obtained from the graph 
[Figure 2].23
2,2-Diphenyl-1-picrylhydrazyl (DPPH) 
Assay
The antioxidant activity of organic solvent soluble 
fractions of plant extract was determined using 
DPPH free radical scavenging assay following 
published article with some modification.24-26 
An aliquot of 300 µl of different concentrations 
(20-500 µg/ml) of each of the extract was mixed with 
3 ml of freshly prepared DPPH solution (0.1 mM) 
in methanol. The reaction mixture was mixed and 
incubated for 30 min at room temperature in dark 
and its absorbance was taken at 517 nm. Ascorbic 
acid was used as the reference standard. The DPPH 
scavenging capability was calculated using the 
following equation- 
Where, Abs (control) is the absorbance of the 
DPPH radical in methanol; Abs (sample) is the 
absorbance of the DPPH solution in presence of 
the respective solvent soluble (pet ether and chloro-
form) extract or standard. The antioxidant activity 
was expressed as IC50, and the IC50 was calculated 
by the equation (Y = mX + C; when Y = 50, X = 
IC50) obtained from the graph [Figure 2]. 
Ferric Reducing Antioxidant Power Assay
The reducing potential of plant extract was deter-
mined by following the method described by Chen 
and Khantaphant with little modification.27,28 The 
FRAP reagent was freshly prepared by mixing 
of 100  mL acetate buffer (300 mM, pH 3.6), 
10 mL of TPTZ solution (10 mM TPTZ in 40 mL 
Hydrochloric acid) and 10 mL of ferric chloride 
heptahydrate (20mM). The solution was warmed at 
37 ºC for 30 min under dark condition. The FRAP 
reagent (3 mL) was then added to 0.3 mL of various 
concentration of plant extract or absolute methanol 
(blank). The mixture was incubated for 5 min in 
dark and the absorbance was measured at 593 nm. 
The antioxidant potential (EC50) of the sample 
was calculated from a linear regression analysis 
[Figure 2] and compared with standard of ascorbic 
acid.
Statistical Analysis
The results were presented as mean ± standard 
error of mean (SEM). The one-way ANOVA with 
Dunnett’s post hoc test was used to analyze and 
compare the data using GraphPad Prism version-5 
(GraphPad Software, San Diego California USA)., 
while < 0.05–0.001 were considered statistically 
significant value.
RESULTS
The whole plant extract of A. ilicifolius was tested 
to check the analgesic activity in mice model. The 
pet ether and chloroform extract was evaluated 
for possible analgesic activity by 0.6% acetic acid 
Table 1  Analgesic activity of whole plant extract of A. ilicifolius on Swiss albino mice
Group Treatment
Number of writhing 
(Mean ± SEM)
% inhibition of 
analgesic activity
I DW (10 ml/kgbw) 55 ± 4.03 ─
II Standard Diclofenac (100 mg/kgbw) 25.94 ± 1.58*** 52.79 ± 2.62
III Pet Ether extract (200 mg/kgbw) 40.67 ± 1.95*** 26.06 ± 1.14
IV Pet Ether extract (400 mg/kgbw) 32.94 ± 1.5*** 40.14 ± 2.32
V Chloroform extract (200 mg/kgbw) 43.89 ± 2.01* 20.79 ± 4.12
VI Chloroform extract (400 mg/kgbw) 32.94 ± 1.53*** 40.12 ± 0.90
Results are expressed in Mean ± SEM of three independent experiment and p* < 0.05, p** < 0.01, p*** < 0.001 were considered as 
statistically significant value.
Figure 1  Number of writhing in Swiss albino 
mice after post oral administration 
of DW, plant extract, and standard 
diclofenac. Pain was induced by perito-
neal administration of 0.6% acetic acid 
and writhing was counted up to 15 min-
utes. Results were expressed in Mean ± 
SEM of six mice in each group and 
three independent experimental results 
were shown
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induced writhing method. The effect of pet ether 
and chloroform soluble fraction of plant extract 
and standard diclofenac was compared with control 
(DW). The writhing number in control (DW) 
group of mice was found to be high compare to test 
sample and standard drug [Figure 1]. 
Both of pet ether and chloroform extract was 
found to provide analgesic activity in a dose depen-
dent fashion. The percent of analgesic activity was 
found to be (26.06 ± 1.4)% at 200 mg/kgbw and 
(40.14 ± 2.32)% at 400 mg/kgbw concentration 
[Table 1]. On the other hand chloroform extract 
showed (20.79 ± 4.12)% analgesic inhibitions at 
200 mg/kgbw and (40.12 ± 0.9)% at 400 mg/kgbw 
concentration, respectively. The standard drug 
diclofenac revealed inhibition of analgesic activ-
ity by (52.79 ± 2.62)% at a concentration of 
100 mg/kgbw [Table 1]. Compare to standard drug 
diclofenac, the plant extract provide moderate anal-
gesic activity, which is reasonable.
Figure 2  DPPH scavenging activity, ferric reducing antioxidant power assay, and reducing power assay of standard ascorbic acid, 
pet ether and chloroform soluble fractions of whole plant extract of A. ilicifolius
Figure 3  The EC50 value (µg/ml) of ascorbic acid, 
pet ether, and chloroform soluble frac-
tions in reducing power assay. Results 
are expressed in Mean ± SEM of three 
independent experiment and p* < 0.05, 
 p** < 0.01, p*** < 0.001 were consid-
ered as statistically significant value
Figure 4  The IC50 value (µg/ml) of DPPH scav-
enging effect of ascorbic acid, pet ether, 
and chloroform soluble fractions. Results 
are expressed in Mean ± SEM of three 
independent experiment and p* < 0.05, 
p** < 0.01, p*** < 0.001 were considered 
as statistically significant value
Figure 5  The EC50 value (µg/ml) of ferric reduc-
ing antioxidant power activity of ascor-
bic acid, pet ether, and chloroform 
soluble fractions. Results are expressed 
in Mean ± SEM of three independent 
experiment and p* < 0.05, p** < 0.01, 
p*** < 0.001 were considered as statis-
tically significant value
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The whole plant extracts of pet ether and chlo-
roform fraction was also subjected to evaluate the 
possible antioxidant activity. The plant extracts may 
possess different phytochemical constituents which 
provided antioxidant activity.29 In reducing power 
assay, the pet ether and chloroform fraction of plant 
extracts showed potential antioxidant activity. The 
absorbance for antioxidant activity was concen-
tration dependent and showed linear increment 
of absorbance value with increase concentration 
of plant extract as like standard ascorbic acid. The 
EC50 value of pet ether and chloroform fraction 
were obtained (292.7 ± 8.37) µg/ml, and (221.3 ± 
2.96) µg/ml, respectively [Figure 3]. The standard 
ascorbic acid showed EC50 value of (90 ± 10.89) µg/ml. 
From the results, it is to be mentioned that the 
antioxidant potential of pet ether and chloroform 
soluble fractions are low to moderate compare to 
standard ascorbic acid.
In DPPH scavenging activity assay, the plant 
extract was also showed antioxidant potential at a 
similar fashion as like reducing power assay. The 
percent inhibition of scavenging activity was shown 
to be concentration dependent and was found 
to be increased with plant extract concentration 
[figure  2]. To better understand the antioxidant 
activity, IC50 value was calculated from the graph 
and derived equation. The IC50 value of pet ether 
and chloroform fraction of plant extract was shown 
to be (169.4 ± 8.86) µg/ml and (146.6 ± 5.39) µg/ml, 
respectively [Figure 4]. Standard ascorbic acid 
revealed the IC50 value of (91.07 ± 2.31) µg/ml.
In FRAP assay, the plant extract showed anti-
oxidant activity as like DPPH and reducing power 
assay. The absorbance was found to be increased 
with the concentration of plant extract up to a 
level, then found to be constant at higher concen-
trations [Figure 2]. The EC50 value of pet ether and 
chloroform fraction of plant extract was found to 
be (313 ± 14.57) µg/ml and (242.7 ± 3.52) µg/ml, 
respectively [Figure 5]; whereas, the EC50 value for 
standard ascorbic acid was found to be (138.0 ± 
23.26) µg/ml [Figure 5].
DISCUSSION
Inflammation is the common sign and symptom 
of expressing body abnormalities by any exter-
nal injuries, edema, and pathological situation 
in human. During the pathological situation, 
body response to external hit, trauma, bacterial 
infection or any other injury with inflammation. 
Conventional NSAIDs are used to treat inflam-
mation, pain, bruise and edema. However, severe 
side effects and toxicity is major concern during 
the choice of treatment regimen. To overcome 
the treatment limitation and avoid adverse effects, 
finding of new molecular entities is prime concern 
of researcher. However, new molecular entities 
could be synthesized in synthetic laboratories; the 
medicinal plants are considered as a major source 
due to more toxic nature of synthetic drug.5 In this 
study, pet ether and chloroform soluble fractions 
of whole plant extract of A. ilicifolius was evaluated 
for possible anti-inflammatory activity by acetic 
acid induced writhing in Swiss albino mice model. 
The results revealed that, the whole plant extracts 
of A. ilicifolius possesses significant anti-inflamma-
tory activities [Figure 1 and Table 1].
Intraperitoneal administration of acetic acid 
induces capillary permeability and fluid infiltra-
tion with protein exudation. The event produces 
acute inflammation which is express by writhing 
of abdomen. Besides, during the inflammation, 
leukocytes and macrophage migrates to the side of 
injuries and produce hydrogen peroxide. Hydrogen 
peroxide may transform highly reactive hydroxyl 
radical in the presence of transitional elements. 
This hydroxyl radical may acts as second messen-
ger to activate inflammatory mediators.30 In this 
study, antioxidant activity by different method like 
DPPH scavenging activity, FRAP assay, reducing 
power assay revealed the significant antioxidant 
activity of whole plant extract of A. ilicifolius. These 
antioxidants may inhibit the generation of reactive 
oxygen species and pro-inflammatory mediators 
to prevent the generation of inflammation as like 
aspirin.31 Even more, the phytochemical bioactive 
compounds in A. ilicifolius may inhibit inflam-
mation by modulating cyclooxigenase─1 and 
2 (COX─1 and COX─2), lipooxygenase (LOX), and 
nuclear transcription factor (NF-κB).32,33 The plant 
extract is found to be decreased protein exudation 
and leukocyte migration in the peritoneal fluid, 
indicating its effectiveness towards inhibition of 
peritoneal inflammation.5
Free radicals are responsible for the genera-
tion of cancer by means of different steps. Most 
commonly, reactive oxygen species and nitrogen 
species could facilitate cancer development by 
damaging of DNA and other biomolecular compo-
nents.34 Chemotherapeutic drugs are the first choice 
of cancer treatment; however they can trigger 
enormous side effects. Considering this drawback, 
research on phytochemical screening and discov-
ering anticancer drug is becoming attractive to the 
researcher day by day. The phytochemical compo-
nents in medicinal plants are believed to inhibit 
carcinogenesis and several studies showed that the 
antioxidant compounds exert cytotoxic effect on 
tumor cells and in in─vivo animal model.35-37 Thus, 
the possible antioxidant potential of pet ether and 
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chloroform soluble fraction of whole plant extract 
of A. ilicifolius was evaluated. 
In antioxidant test, the DPPH scavenging 
activity assay showed DPPH scavenging with the 
increasing concentration of plant extract [Figure 2]. 
The IC50 value of pet ether and chloroform fraction 
was found to be fair proximity of standard ascor-
bic acid. Result of free radical scavenging activity 
can be varied depending on several factors such 
as, stereo selectivity of the radicals, solubility of 
the extract in different solvent systems, polarity of 
solvent, and functional group present in bioactive 
compounds. The results of this study suggesting 
possible antioxidant activity of plant extract which 
may use in the treatment of free radical induced 
pathological damages.38 
In FRAP assay, it has been shown that the absor-
bance is increased steadily with the increase of plant 
extract concentration indicating potential antioxi-
dant activity. The EC50 value of pet ether and chlo-
roform fraction was found to be higher, however it 
was near to standard ascorbic acid value. In reduc-
ing power assay, both of pet ether and chloroform 
fraction showed moderate antioxidant activity as 
like DPPH and FRAP assay. The EC50 value of pet 
ether and chloroform soluble fractions was found to 
be (313.0 ± 14.57) µg/ml and (242.7 ± 3.52) µg/ml, 
respectively. Standard ascorbic acid showed the EC50 
value of (138.0 ± 23.26) µg/ml. From the results, it 
has been implied that, the plant extract possesses 
moderate to low ferric reducing capability.
In conclusion, the pet ether and chloroform 
soluble fraction of whole plant extract of A. ilici-
folius showed potential analgesic and antioxidant 
activities. However, it is highly necessary to isolate 
the single compound and to evaluate the mentioned 
activities by single compound for better under-
standing of plant medicinal value. 
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